ATE254137T1 - ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN - Google Patents

ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN

Info

Publication number
ATE254137T1
ATE254137T1 AT99947256T AT99947256T ATE254137T1 AT E254137 T1 ATE254137 T1 AT E254137T1 AT 99947256 T AT99947256 T AT 99947256T AT 99947256 T AT99947256 T AT 99947256T AT E254137 T1 ATE254137 T1 AT E254137T1
Authority
AT
Austria
Prior art keywords
lpa
ßligand
assemblyß
presenting
production
Prior art date
Application number
AT99947256T
Other languages
English (en)
Inventor
Arne Holm
Rikke Malene Jorgensen
Soren Ostergaard
Michael Theisen
Original Assignee
Statens Seruminstitut
Arne Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut, Arne Holm filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE254137T1 publication Critical patent/ATE254137T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
    • A61K2039/645—Dendrimers; Multiple antigen peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Liquid Crystal Substances (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99947256T 1998-09-29 1999-09-29 ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN ATE254137T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801233 1998-09-29
PCT/DK1999/000510 WO2000018791A1 (en) 1998-09-29 1999-09-29 Ligand presenting assembly (lpa), method of preparation and uses thereof

Publications (1)

Publication Number Publication Date
ATE254137T1 true ATE254137T1 (de) 2003-11-15

Family

ID=8102501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99947256T ATE254137T1 (de) 1998-09-29 1999-09-29 ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN

Country Status (6)

Country Link
US (1) US20040086949A1 (de)
EP (1) EP1117677B1 (de)
AT (1) ATE254137T1 (de)
AU (1) AU6078399A (de)
DE (1) DE69912827T2 (de)
WO (1) WO2000018791A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE552273T1 (de) 2001-08-17 2012-04-15 Enkam Pharmaceuticals As Verbindungen, die die differenzierung, proliferation, regeneration, plastizität und das überleben von zellen beeinflussen können
US20090105149A1 (en) * 2003-08-07 2009-04-23 Enkam Pharmaceuticals A/S Compounds comprising lpa
EP1711208A2 (de) * 2004-01-28 2006-10-18 Curix APS Konjugate von amyloid-proteinen als impfstoffe gegen amyloid-bedingte erkrankungen
EP2385061A3 (de) 2005-05-10 2012-02-22 Neoloch Aps Neuritogene peptide
WO2007093177A2 (en) 2006-02-14 2007-08-23 Vladimir Berezin Metallothionein-derived peptide fragments
EP2089052A4 (de) * 2006-05-24 2011-02-16 Peg Biosciences Peg-linker-verbindungen und ihre biologisch wirksamen konjugate
ES2585702T3 (es) * 2007-05-30 2016-10-07 Lpath, Inc Composiciones y métodos para la unión al ácido lisofosfatídico
WO2009068042A2 (en) 2007-11-28 2009-06-04 Enkam Pharmaceuticals A/S Novel peptides derived from ncam (fgls)
CN103229055A (zh) * 2010-09-27 2013-07-31 康奈尔大学 莱姆病的诊断方法
WO2014093196A1 (en) * 2012-12-10 2014-06-19 North Carolina State University Solid phase scaffold based libraries
US10450343B2 (en) * 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596792A (en) * 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
US4599231A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) * 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) * 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
DE69718903T2 (de) * 1996-05-02 2003-12-04 Dakocytomation Denmark A/S, Glostrup Verwendung von aus osp-c abgeleiteten peptidefragmenten für diagnostische methoden
JP2001509796A (ja) * 1997-01-29 2001-07-24 ニユコメド・イメージング・アクシエセルカペト 重合体

Also Published As

Publication number Publication date
DE69912827D1 (de) 2003-12-18
DE69912827T2 (de) 2004-10-21
WO2000018791A1 (en) 2000-04-06
EP1117677B1 (de) 2003-11-12
US20040086949A1 (en) 2004-05-06
AU6078399A (en) 2000-04-17
EP1117677A1 (de) 2001-07-25

Similar Documents

Publication Publication Date Title
ATE475883T1 (de) Verfahren zur messung der wirkstärke von glatirameracetat
ATE278390T1 (de) Verfahren zur herstellung von arzneistoffpartikeln
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DE60004479D1 (de) Verfahren zur herstellung von phytosterol- oder phytostanol-mikropartikeln
SE9704546D0 (sv) Novel compounds
DE69111440D1 (de) Methoden und zusammensetzungen zur impfung gegen hiv.
TR200103018T2 (tr) İmmünostimülatör oligonükleotid ve saponin içeren katkı bileşikleri.
DE60224942D1 (de) Komponenten und verfahren für die verbesserte herstellung von abdrücken
DE122007000082I1 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
ATE223413T1 (de) Neuartige verbindungen
ATE430207T1 (de) Genomische sequenzen von neisseria und verfahren zu ihrer verwendung
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
DE60015084D1 (de) Verbesserung der bakterizidaktivität von neisseria antigenen mit cg enthaltende oligonukleotiden
ATE254137T1 (de) ßLIGAND PRESENTING ASSEMBLYß (LPA), VERFAHREN ZU DESSEN HERSTELLUNG UND VERWENDUNGEN
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE69104365D1 (de) Vaterit und verfahren zu dessen herstellung.
ATE202483T1 (de) Immuntolerante prothrombinkomplex-präparation
FI923385A7 (fi) Menetelmä syklosporiinia sisältävän, suun kautta annettavan farmaseutt isen koostumuksen valmistamiseksi
DE69530380D1 (de) Retropeptide, antikörper dagegen und deren verwendungen in der impfung und in vitro diagnostik
DE69517191D1 (de) Wasserlösliche derivate epipodophyllotoxine, verfahren zu ihrer herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
ES2156105T3 (es) Derivados de amino-fenoles sustituidos en n y o, productos intermedios para su preparacion, su utilizacion como substratos para hidrolasas, un correspondiente procedimiento de determinacion y un agente de diagnostico apropiado para ello.
ATA156590A (de) Mono-(2-ammonium-2-hydroxymethyl-1,3-propandiol (2r,cis)-1,2-epoxypropylphosphonat und verfahren zu dessen herstellung sowie pharmazeutische zusammensetzungen
FR2819395B1 (fr) Implant dentaire transitoire de preparation d'une alveole
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties